Search Results - "Greenzaid, Jonathan D"

Colchicine vs pentoxifylline vs minocycline for generalized granuloma annulare: A retrospective cohort study by Greenzaid, Jonathan D., Hrin, Matthew L., Feldman, Steven R., Strowd, Lindsay C.

Get full text

Atopic dermatitis may not confer clinically meaningful risk of inflammatory bowel disease or renal malignancy by Gantz, Hannah Y., Greenzaid, Jonathan D., Feldman, Steven R.

Get full text

Methotrexate and acitretin in pityriasis rubra pilaris: A retrospective cohort study by Greenzaid, Jonathan D., Hrin, Matthew L., Feldman, Steven R., Strowd, Lindsay C.

Get full text

Wait times for surgery of cutaneous malignancies following the COVID-19 pandemic: a retrospective cohort analysis by Cleland, Jane B., Greenzaid, Jonathan D., Doerfler, Laura, Ahn, Christine S.

Get full text

Quality of Photographs of Lesions Referred for Dermatologic Surgery at an Academic Medical Center by Greenzaid, Jonathan D, Hrin, Matthew L, Haidari, Wasim, Ahn, Christine S, Doerfler, Laura, Feldman, Steven R

Get full text

Management of atopic dermatitis in patients non‐responsive to dupilumab: A single‐centre retrospective‐cohort study by Greenzaid, Jonathan D., Hrin, Matthew L., Feldman, Steven R., Strowd, Lindsay C.

Get full text

Clinical pharmacokinetics and pharmacodynamics of topical non-biological therapies for psoriasis patients by Lo, Angela, Greenzaid, Jonathan D, Gantz, Hannah Y, Chodri, Kamran, Feldman, Steven R

“…Psoriasis is a chronic inflammatory cutaneous disease that causes patients psychosocial distress. Topical therapies are utilized for mild-to-moderate disease…”
Get more information

Clinical pharmacokinetics and pharmacodynamics of oral systemic nonbiologic therapies for psoriasis patients by Eichinger, Justin M, Shan, Divya M, Greenzaid, Jonathan D, Anakwenze, Lisa, Feldman, Steven R

“…Psoriasis is a chronic inflammatory immune condition. Treatments for psoriasis vary with disease severity, ranging from topicals to systemic biologic agents…”
Get more information

Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases by Fowler, Alan J, Hebron, Michaeline, Balaraman, Kaluvu, Shi, Wangke, Missner, Alexander A, Greenzaid, Jonathan D, Chiu, Timothy L, Ullman, Clementina, Weatherdon, Ethan, Duka, Val, Torres-Yaghi, Yasar, Pagan, Fernando L, Liu, Xiaoguang, Ressom, Habtom, Ahn, Jaeil, Wolf, Christian, Moussa, Charbel

“…Abstract The role of Discoidin Domain Receptors (DDRs) is poorly understood in neurodegeneration. DDRs are upregulated in Alzheimer’s and Parkinson’s disease…”
Get full text

Non-Steroidal Topical Therapies for Early-Stage Mycosis Fungoides: A Retrospective Cohort Study by Greenzaid, Jonathan D., Hrin, Matthew L., Feldman, Steven R., Strowd, Lindsay C.

Get full text

Does atopic dermatitis confer a clinically meaningful risk of cardiovascular disease? by Chalupczak, Natalia V., Greenzaid, Jonathan D., Feldman, Steven R.

Get full text

Analyzing the Benefits and Costs of the Safe Step Act on Patients, Physicians, and Insurers by Shan, Divya M., Greenzaid, Jonathan D., Greene, Estay, Feldman, Steven R.

“…Pharmaceutical expenditures in the United States, particularly in dermatology, have grown rapidly, driven by expensive topical and biologic treatments…”
Get full text

Adherence to treatment in dermatology: Literature review by Lo, Angela, Lovell, Katie K., Greenzaid, Jonathan D., Oscherwitz, Max E., Feldman, Steven R.

“…Poor adherence to therapies in dermatology remains a prevalent issue associated with treatment failure, poor clinical outcomes, and reduced quality of life…”
Get full text

Evaluation of public perception towards patients with hidradenitis suppurativa and atopic dermatitis by Greenzaid, Jonathan D., Johnson, Matthew C., Feldman, Steven R.

Get full text

Implementation of the atopic dermatitis yardstick via the electronic medical record: a pilot study to improve clinical documentation and patient education by Greenzaid, Jonathan D, Pixley, Jessica N, Kelly, Katherine A, Feldman, Steven R, Strowd, Lindsay C

Get full text

Erratum to: Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases by Fowler, Alan J, Hebron, Michaeline, Balaraman, Kaluvu, Shi, Wangke, Missner, Alexander A, Greenzaid, Jonathan D, Chiu, Timothy L, Ullman, Clementina, Weatherdon, Ethan, Duka, Val, Torres-Yaghi, Yasar, Pagan, Fernando L, Liu, Xiaoguang, Ressom, Habtom, Ahn, Jaeil, Wolf, Christian, Moussa, Charbel

Get full text